Protective effect of tonapofylline (BG9928), an adenosine A1 receptor antagonist, against cisplatin-induced acute kidney injury in rats

American Journal of Nephrology

Volumn 30, Issue 6, 2009, Pages 521-526

  Gill, Alan ^a   Wortham, Kathleen ^a   Costa, Don ^a   Davis, Wendell ^a   Ticho, Barry ^a   Whalley, Eric ^a  

^a BIOGEN   (United States)

Author keywords

Acute kidney injury; Adenosine antagonist; BG9928; Cisplatin; Tonapofylline

Indexed keywords

3 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)BICYCLO[2.2.2]OCTAN 1 YL]PROPIONIC ACID; CISPLATIN; CREATININE; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; FEMALE; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY MEDULLA; KIDNEY TUBULE DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD UREA NITROGEN; CISPLATIN; CREATININE; CYTOPROTECTION; DRUG INTERACTIONS; FEMALE; GLUCOCORTICOIDS; KIDNEY FUNCTION TESTS; KIDNEY TUBULES, PROXIMAL; PREDNISOLONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; RENAL INSUFFICIENCY, ACUTE; XANTHINES;

EID: 70349892293     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000248762     Document Type: Article

References (39)

1. Ward JM, Grabin ME, Berlin E, Young DM: Prevention of renal failure in rats receiving cis-diamminedichloroplatinum(II) by administration of furosemide. Cancer Res 1977; 37: 1238-1240.
2. Loehrer PJ, Einhorn LH: Drugs five years later. Cisplatin. Ann Intern Med 1984; 100: 704-713.
3. Hanigan MH, Devarajan P: Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 2003; 1: 47-61.
4. Chopra S, Kaufman JS, Jones TW, Hong WK, Gehr MK, Hamburger RJ, Flamenbaum W, Trump BF: Cis-diamminedichloroplatinum- induced acute renal failure in the rat. Kidney Int 1982; 21: 54-64.
5. Winston JA, Safirstein R: Reduced renal blood flow in early cisplatin-induced acute renal failure in the rat. Am J Physiol 1985; 249:F490-F496.
6. Ross DA, Gale GR: Reduction of the renal toxicity of cis- dichlorodiammineplatinum (II) by probenecid. Cancer Treat Rep 1979; 63: 781-787.
7. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J: International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 527-552.
8. Schnermann J, Briggs JP: Tubuloglomerular feedback: mechanistic insights from genemanipulated mice. Kidney Int 2008; 74: 418-426.
9. Osswald H, Vallon V, Mühlbauer B: Role of adenosine in tubuloglomerular feedback and acute renal failure. J Auton Pharmacol 1996; 16: 377-380.
10. Aki Y, Tomohiro A, Nishiyama A, Kiyomoto K, Kimura S, Abe Y: Effects of KW-3902, a selective and potent adenosine A 1 receptor antagonist, on renal hemodynamics and urine formation in anesthetized dogs. Pharmacology 1997; 55: 193-201.
11. Wilcox CS, Welch WJ, Schreiner GF, Belardinelli L: Natriuretic and diuretic actions of a highly selective adenosine A 1 receptor antagonist. J Am Soc Nephrol 1999; 10: 714-720.
12. Bak M, Thomsen K: Effects of the adenosine A 1 receptor inhibitor FK 838 on proximal tubular fluid output in rats. Nephrol Dial Transplant 2004; 19: 1077-1082.
13. Mizumoto H, Karasawa A: Effects of adenosine A 1 -agonist and -antagonist on urinary volume and Na excretion in IAP-treated and non-treated rats. Jpn J Pharmacol 1993; 63: 257-259.
14. Bhat SG, Mishra S, Mei Y, Nie Z, Whitworth CA, Rybak LP, Ramkumar V: Cisplatin upregulates the adenosine A(1) receptor in the rat kidney. Eur J Pharmacol 2002; 442: 251-264.
15. Heidemann HT, Müller S, Mertins L, Stepan G, Hoffmann K, Ohnhaus EE: Effect of aminophylline on cisplatin nephrotoxicity in the rat. Br J Pharmacol 1989; 97: 313-318.
16. Knight RJ, Collis MG, Yates MS, Bowmer CJ: Amelioration of cisplatin-induced acute renal failure with 8-cyclopentyl-1,3-dipropylxanthine. Br J Pharmacol 1991; 104: 1062-1068.
17. Yao K, Kusaka H, Sano J, Sato K, Karasawa A: Diuretic effects of KW-3902, a novel adenosine A 1 -receptor antagonist, in various models of acute renal failure in rats. Jpn J Pharmacol 1994; 64: 281-288. (Pubitemid 24157222)
18. Nagashima K, Kusaka H, Karasawa A: Protective effects of KW-3902, an adenosine A 1 - receptor antagonist, against cisplatin-induced acute renal failure in rats. Jpn J Pharmacol 1995; 67: 349-357.
19. Benoehr P, Krueth P, Bokemeyer C, Grenz A, Osswald H, Hartmann JT: Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, singleblinded, placebo-controlled trial. J Am Soc Nephrol 2005; 16: 452-458.
20. Ticho B, Whalley, E, Gill A, Lutterodt F, Jin X, Auchampach J, Smits G: Renal effects of BG9928, an A 1 adenosine receptor antagonist, in rats and nonhuman primates. Drug Dev Res 2003; 58: 486-492.
21. Kiesman WF, Zhao J, Conlon PR, Dowling JE, Petter RC, Lutterodt F, Jin X, Smits G, Fure M, Jayaraj A, Kim J, Sullivan G, Linden J: Potent and orally bioavailable 8-bicyclo- [2.2.2]octylxanthines as adenosine A1 receptor antagonists. J Med Chem 2006; 49: 7119-7131. (Pubitemid 44885997)
22. Auchampach JA, Jin X, Moore J, Wan TC, Kreckler LM, Ge ZD, Narayanan J, Whalley E, Kiesman W, Ticho B, Smits G, Gross GJ: Comparison of three different A 1 adenosine receptor antagonists on infarct size and multiple cycle ischemic preconditioning in anesthetized dogs. J Pharmacol Exp Ther 2004; 308: 846-856.
23. Lucas DG Jr, Hendrick JW, Sample JA, Mukherjee R, Escobar GP, Smits GJ, Crawford FA Jr, Spinale FG: Cardiorenal effects of adenosine subtype 1 (A 1 ) receptor inhibition in an experimental model of heart failure. J Am Coll Surg 2002; 194: 603-609.
24. Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT: Effects of multiple oral doses of an A 1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo- controlled, dose-escalation study. J Am Coll Cardiol 2007; 50: 600-606.
25. Koikawa Y, Uozumi J, Ueda T, Yasumasu T, Kumazawa J: Prophylactic effect of methylprednisolone against cisplatin-induced nephrotoxicity in rats. Toxicol Lett 1993; 66: 281-285.
26. Vallon V, Miracle C, Thomson S: Adenosine and kidney function: potential implications in patients with heart failure. Eur J Heart Fail 2008; 10: 176-187.
27. Jackson EK, Zhu C, Tofovic SP: Expression of adenosine receptors in the preglomerular microcirculation. Am J Physiol Renal Physiol 2002; 283:F41-F51.
28. Vitzthum H, Weiss B, Bachleitner W, Krämer BK, Kurtz A: Gene expression of adenosine receptors along the nephron. Kidney Int 2004; 65: 1180-1190.
29. Vallon V, Mühlbauer B, Osswald H: Adenosine and kidney function. Physiol Rev 2006; 86: 901-940.
30. Gabriëls G, Endlich K, Rahn KH, Schlatter E, Steinhausen M: In vivo effects of diadenosine polyphosphates on rat renal microcirculation. Kidney Int 2000; 57: 2476-2484.
31. Dietrich MS, Steinhausen M: Differential reactivity of cortical and juxtamedullary glomeruli to adenosine-1 and adenosine-2 receptor stimulation and angiotensin-converting enzyme inhibition. Microvasc Res 1993; 45: 122-133.
32. Holz FG, Steinhausen M: Renovascular effects of adenosine receptor agonists. Ren Physiol 1987; 10: 272-282.
33. Jackson EK, Mi Z, Herzer WA: Studies on the mechanism by which adenosine receptor antagonists attenuate acute renal failure; in Belardinelli L, Pelleg A (eds): Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology. Boston, Kluwer Academic Publishers, 1995, pp 415- 423.
34. Yasumasu T, Ueda T, Uozumi J, Mihara Y, Kumazawa J: Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats. Pharmacol Toxicol 1992; 70: 143-147.
35. Berens KL, Verani RR, Luke DR: Role of neutrophils and macrophages in experimental nephrosis of the rat. Ren Fail 1998; 20: 53-63.
36. Uozumi J, Koikawa Y, Yasumasu T, Tokuda N, Ueda T, Kumazawa J: The effect of methylprednisolone on platinum kinetics and urinary enzyme excretion following intravenous cisplatin in vivo and on the growth of LLC-PK1 cells by cisplatin in vitro. Exp Med (Berl) 1996; 196: 211-217.
37. Min KS, Kim H, Fujii M, Tetsuchikawahara N, Onosaka S: Glucocorticiods suppress the inflammation-mediated tolerance to acute toxicity of cadmium in mice. Toxicol Appl Pharmacol 2002; 178: 1-7.
38. Uozumi J, Koikawa Y, Yasumasu T, Ueda T, Kumazawa J: The effect of methylprednisolone on cisplatin-induced nephrotoxicity in rat renal cortical slices. Res Exp Med (Berl) 1995; 195: 231-235.
39. Nie Z, Mei Y, Ford M, Rybak L, Marcuzi A, Ren H, Stiles GL, Ramkumar V: Oxidative stress increases A 1 adenosine receptor expression by activating nuclear factor kB. Mol Pharmacol 1997; 53: 663-669.